278 related articles for article (PubMed ID: 21269274)
1. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
Yan X; Chen YG
Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Smad7: emerging roles in health and disease.
Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
5. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
6. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
7. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
8. Non-Smad TGF-beta signals.
Moustakas A; Heldin CH
J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
[TBL] [Abstract][Full Text] [Related]
9. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
10. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
[TBL] [Abstract][Full Text] [Related]
11. Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus.
Yan X; Pan J; Xiong W; Cheng M; Sun Y; Zhang S; Chen Y
Sci China Life Sci; 2014 Jan; 57(1):128-36. PubMed ID: 24369345
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
Weng H; Mertens PR; Gressner AM; Dooley S
J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish Smad7 is regulated by Smad3 and BMP signals.
Pogoda HM; Meyer D
Dev Dyn; 2002 Jul; 224(3):334-49. PubMed ID: 12112463
[TBL] [Abstract][Full Text] [Related]
14. Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models.
Xiao H; Zhang YY
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):335-41. PubMed ID: 18290874
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta superfamily signaling is essential for tooth and hair morphogenesis and differentiation.
Klopcic B; Maass T; Meyer E; Lehr HA; Metzger D; Chambon P; Mann A; Blessing M
Eur J Cell Biol; 2007 Dec; 86(11-12):781-99. PubMed ID: 17499880
[TBL] [Abstract][Full Text] [Related]
16. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
18. Current perspectives on inhibitory SMAD7 in health and disease.
de Ceuninck van Capelle C; Spit M; Ten Dijke P
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
[TBL] [Abstract][Full Text] [Related]
19. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1.
Boon RA; Fledderus JO; Volger OL; van Wanrooij EJ; Pardali E; Weesie F; Kuiper J; Pannekoek H; ten Dijke P; Horrevoets AJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):532-9. PubMed ID: 17194892
[TBL] [Abstract][Full Text] [Related]
20. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
